Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.56 |
| ▸ | PKM | P14618 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16592104 | 0.92 | NPSR1 (0.55) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL7901272 | 0.90 | NPSR1 (0.53) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL22809569 | 0.86 | PKM (0.52) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL22809528 | 0.84 | PKM (0.57) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL14234223 | 0.81 | PKM (0.51) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL29958095 | 0.79 | NPSR1 (0.40) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL6970770 | 0.78 | PKM (0.50) | NPSR1PKMSMN1; SMN2KMT2AKDM4E | |
| SCHEMBL14234225 | 0.76 | PKM (0.53) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL7821174 | 0.76 | PKM (0.65) | NPSR1PKMLMNASMN1; SMN2KMT2A | |
| SCHEMBL2655252 | 0.76 | PLAU (0.37) | NPSR1PKMLMNAKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023532-B2 | Alkyl phenyl sulfide derivative and pest control agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2018-07-17 | — | — | US | disclosed |
| US-6407245-B2 | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-18 | — | — | US | disclosed |
| US-20010012897-A1 | Substituted thiopyridines | HAMPRECHT GERHARD (DE) | 2001-08-09 | — | — | US | disclosed |
| US-6262273-B1 | REACTING A3-CHLORO-2-HALOPYRIDINE WITH THIO COMPOUND IN PRESENCE OF TRIFLUOROACETIC ACID OR PERCHLORIC ACID TO GIVE PYRIDINE THIOETHER COMPOUND WHICH IS OXIDIZED TO GIVE THIOPYRIDINE COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | disclosed |
| US-6191280-B1 | REACTING SUBSTITUTED 2-HALOPYRIDINE DERIVATIVE WITH A THIO COMPOUND IN PRESENCE OF COPPER CATALYST TO GIVE A PYRIDINE THIOETHER, AND THEN OXIDIZING THE THIOETHER INTERMEDIATE TO FORM SULFOXIDE OR SULFONE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-20 | — | — | US | disclosed |
| EP-0984935-A1 | METHOD FOR PRODUCING SUBSTITUTED THIOPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-15 | — | — | EP | disclosed |
| EP-0934275-A1 | SUBSTITUTED THIOPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998054139-A1 | METHOD FOR PRODUCING SUBSTITUTED THIOPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 1998-12-03 | — | — | WO | disclosed |
| WO-1998011072-A1 | SUBSTITUTED THIOPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010012897-A1 | Substituted thiopyridines | CBR1, CLIC1, CBR3 | NPSR1 1793/4885PKM 4340/4885LMNA 1928/4885 |
| US-10023532-B2 | Alkyl phenyl sulfide derivative and pest control agent | C1S, TRPA1, STK39 | NPSR1 245/4885PKM 1047/4885LMNA 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.